deltatrials
Completed OBSERVATIONAL NCT01750788

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia (XANAP)

Xarelto® on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Asia: A Non-interventional Study

Sponsor: Bayer

Updated 9 times since 2017 Last updated: Sep 20, 2017 Started: Jan 13, 2013 Primary completion: Oct 12, 2015 Completion: Oct 12, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Atrial Fibrillation and is currently completed. Bayer leads this study, which shows 9 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotCompleted~Oct 2017 – ~Apr 2018 · 6 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Completed

  3. Jul 2024 — Sep 2024 [monthly]

    Completed

  4. Jan 2021 — Jul 2024 [monthly]

    Completed

  5. Jun 2018 — Jan 2021 [monthly]

    Completed

Show 4 earlier versions
  1. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  2. Oct 2017 — Apr 2018 [monthly]

    Completed NA

  3. Feb 2017 — Oct 2017 [monthly]

    Completed NA

    Phase: PHASE4NA

  4. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jan 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
  • Janssen Research & Development, LLC
Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .